Live data · NADAC + Part D CY24 · reviewed daily

Desloratadine (Clarinex)

Histamine-1 Receptor Antagonist class · 6 generic manufacturers · 7 ANDAs filed at FDA.

First FDA approval2013-01-11
Generic availableYes · 6 mfrs
Shortage statusNone
340B exposureunknown
Last updated
NADAC: weekly (every Wed)Part D Formulary: quarterlyPart D Spend: annual (CY24)Orange Book: weeklyShortages: daily
At a glance · the numbers a plan sponsor wants on screen one

$10.5M in CY2024 Part D spend238K claims · 91K beneficiaries · 329 plans surveyed

Lowest NADAC
$0.255/unit
9 NDCs benchmarked, lowest of all strengths.
Average NADAC
$2.22
Across all dosage forms in distribution.
Highest NADAC
$8.85
Wide spread — brand-strength NDCs still in market.
Plans with PA
0 / 329
Zero PA friction across surveyed plans.

Questions a plan sponsor actually asks.

FAQPage schema11 entries indexed · 4 visible
What is Desloratadine used for?

Desloratadine is tracked in Medicare Part D. Specific indication information is not available in our current dataset.

Is there a generic for Desloratadine?

Yes. 7 ANDAs filed at FDA, 6 generic manufacturers currently shipping.

How much does my plan pay for Desloratadine?

Across 329 Part D plans, Desloratadine averages $2.22/unit (NADAC). Lowest available: $0.255/unit. Highest in distribution: $8.85/unit.

Is Desloratadine on the FDA shortage list?

No. Desloratadine is not currently on the FDA Drug Shortage Database.

7 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.

Sources · every number above traces back.

Last refresh15 Oct 2026

Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book (8 approvals on file) · NADAC unit costs: CMS NADAC weekly file (9 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard (CY2024) · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.